Scenarios that move CAH
Cardinal Health, Inc. Common Stock
Scenarios that move CAH: 13 analyses, 10 positive, 3 negative.
- · Opus Genetics receives FDA approval for presbyopia eye drop — ▲ · impact +6 · confidence low · horizon quarters
- · FDA expands ImmunityBio's Anktiva label for bladder cancer — ▲ · impact +21 · confidence medium · horizon weeks
- · Viatris to acquire Pacira for $1.65B in pain portfolio deal — ▲ · impact +10 · confidence low · horizon quarters
- · HALO wins court order blocking Merck's European Keytruda SC — ▲ · impact +14 · confidence low · horizon quarters
- · BDX expands US manufacturing with $19B healthcare investment — ▼ · impact -15 · confidence low · horizon quarters
- · Liquidia stock plunges 57% after UTHR patent setback — ▲ · impact +7 · confidence low · horizon quarters
- · Lilly reports strong weight loss results for new drug — ▲ · impact +38 · confidence low · horizon quarters
- · DBV Technologies files FDA BLA for VIASKIN Peanut patch — ▲ · impact +7 · confidence low · horizon quarters
- · Kodiak Sciences shares soar 178% on positive wet AMD data — ▲ · impact +10 · confidence low · horizon quarters
- · CHMP backs CORT's Lifyorli combo for ovarian cancer — ▲ · impact +7 · confidence low · horizon quarters
- · Cooper Companies faces scrutiny as US channel inventories decline — ▼ · impact -15 · confidence low · horizon quarters
- · ◇ What if… Major Cyberattack Takes Down Two Largest US Health Insurance Claims Processors — ▼ · confidence low
- · Eli Lilly Weight Loss Pill Shows Better Results Than Injectable Competitors In Phase 3 Trial — ▲ · confidence low